Role of the Immune System in the Pathogenesis, Prevention and Treatment of Alzheimer??s Disease
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 20 (2) , 101-113
- https://doi.org/10.2165/00002512-200320020-00002
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- What the evolution of the amyloid protein precursor supergene family tells us about its functionNeurochemistry International, 2000
- The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alphal-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IκB-alphaNeuropharmacology, 1999
- Brief Communication Inhibitory effects of indomethacin on interleukin-1 and nitric oxide production in rat microglia in vitroInternational Journal of Immunopharmacology, 1999
- The possible role of the immune system in Alzheimer’s diseaseExperimental Gerontology, 1998
- Indomethacin Reverses the Microglial Response to Amyloid β-ProteinNeurobiology of Aging, 1998
- NSAIDS inhibit the IL-1β-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2Brain Research, 1997
- Permeability and Residual Plasma Volume of Human, Dutch Variant, and Rat Amyloid β-Protein 1-40 at the Blood–Brain BarrierNeurobiology of Disease, 1997
- Effects of NSAIDs on IL-1β-induced IL-6 mRNA and protein synthesis in human astrocytoma cellsNeuroReport, 1996
- Tissue Distribution of Ibuprofen in a Fatal OverdoseAmerican Journal of Forensic Medicine & Pathology, 1993
- Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease corticesFEBS Letters, 1991